Taking into consideration all six known breast cancer-associated somatic mutations in ADAM12-L, we note an apparent association between the catalytic activity of ADAM12-L mutants and the molecular characteristic of the tumor. This evidence concerns the gene ADAM12 and breast carcinoma.